What does the DAIDS/RSC Safety and Pharmacovigilance team do?

The RSC Safety team receives adverse events reported by sites participating in DAIDS-supported studies, processes the events for review by the DAIDS Medical Officer, and prepares the reports for submission to the Food and Drug Administration (FDA). They work closely with the OPCRO Safety and Pharmacovigilance Team (SPT) to establish internal procedures and develop training on Safety and Adverse Event Reporting to DAIDS for the clinical research sites.

Click on a topic below to view detailed information.